Physician-led metabolic evaluation with evidence-based guidance on peptide-related therapies, body composition and weight management.
Metabolic health is influenced by far more than body weight alone. This physician-led educational hub examines metabolic health, body composition and peptide-related therapies through an evidence-based Internal Medicine perspective.
Schedule a comprehensive evaluation
Related services: Peptide Therapy Los Angeles · Weight Loss Medications · GLP-1 Weight Loss · Nutrition & Body Composition
Metabolic health can involve glucose regulation, blood pressure, lipids, body composition, sleep, physical activity, nutrition and underlying medical conditions. Weight is one marker, but it should be interpreted in the context of the whole patient.
Dr. David Nazarian takes a 360-degree approach that may consider medical history, medications, prior treatment, hormone or vitamin abnormalities when clinically relevant, sleep, nutrition, lifestyle and body composition. Testing is individualized rather than performed identically for every patient.
The term peptide therapy covers many different substances with very different levels of evidence, FDA status and regulatory treatment. Some peptide-based medications are FDA approved for specific indications; other compounds are investigational or have limited human safety and effectiveness data. We do not treat all peptides as interchangeable or assume that emerging therapies are proven.
Explore Peptide Therapy Los Angeles
For eligible patients, evidence-based weight-management treatment may include nutrition, activity, behavioral strategies and prescription medications. The objective is to improve health and body composition while considering safety and long-term maintenance.
Medical Weight Loss · Weight Loss Medications
Changes in weight can reflect changes in both fat and lean tissue. Nutrition, adequate protein, resistance exercise when appropriate and body-composition monitoring can help guide a more complete plan.
Sleep disorders, certain endocrine conditions, nutrient deficiencies and medications can affect energy, appetite, metabolism or the ability to follow a weight-management plan. Evaluation should be driven by symptoms, history and clinical judgment rather than assuming every patient has a hormonal or metabolic abnormality.
No. Peptides span FDA-approved drugs, naturally occurring signaling molecules and investigational compounds. Regulatory and evidence status must be assessed individually.
That question cannot be answered for peptides as a single category. Effects, evidence and risks differ by compound and indication.
When clinically appropriate, evaluation may consider medical conditions, medications, sleep, nutrition, body composition, endocrine factors and other contributors.
David Nazarian, MD is board certified in Internal Medicine with extensive training in obesity medicine and weight management. His evidence-based, integrative approach connects medical evaluation with lifestyle medicine, metabolic health, sleep, nutrition and ongoing follow-up.
Written and medically reviewed by David Nazarian, MD. View physician credentials · Medical Editorial & Review Policy
This page is educational. Availability and appropriateness of any therapy depend on current evidence, regulatory status and individualized medical evaluation.
